IL148572A0 - Self-cleaving rna sequences and their use for the control of protein synthesis - Google Patents

Self-cleaving rna sequences and their use for the control of protein synthesis

Info

Publication number
IL148572A0
IL148572A0 IL14857200A IL14857200A IL148572A0 IL 148572 A0 IL148572 A0 IL 148572A0 IL 14857200 A IL14857200 A IL 14857200A IL 14857200 A IL14857200 A IL 14857200A IL 148572 A0 IL148572 A0 IL 148572A0
Authority
IL
Israel
Prior art keywords
self
control
protein synthesis
rna sequences
cleaving rna
Prior art date
Application number
IL14857200A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL148572A0 publication Critical patent/IL148572A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1048—SELEX

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14857200A 1999-10-15 2000-10-13 Self-cleaving rna sequences and their use for the control of protein synthesis IL148572A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99402552A EP1092777A1 (de) 1999-10-15 1999-10-15 Selbst-schneidende RNA-Sequenzen und deren Verwendung zur Kontrolle der Protein-Synthese
PCT/EP2000/010423 WO2001029234A2 (en) 1999-10-15 2000-10-13 Self-cleaving rna sequences and their use for the control of protein synthesis

Publications (1)

Publication Number Publication Date
IL148572A0 true IL148572A0 (en) 2002-09-12

Family

ID=8242144

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14857200A IL148572A0 (en) 1999-10-15 2000-10-13 Self-cleaving rna sequences and their use for the control of protein synthesis

Country Status (16)

Country Link
EP (2) EP1092777A1 (de)
JP (1) JP2003512059A (de)
KR (1) KR20020037384A (de)
CN (1) CN1377414A (de)
AU (1) AU784832B2 (de)
BR (1) BR0014632A (de)
CA (1) CA2387185A1 (de)
CZ (1) CZ20021313A3 (de)
HU (1) HUP0203268A3 (de)
IL (1) IL148572A0 (de)
MX (1) MXPA02002864A (de)
NO (1) NO20021713L (de)
NZ (1) NZ518396A (de)
PL (1) PL355165A1 (de)
WO (1) WO2001029234A2 (de)
ZA (1) ZA200202823B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858390B2 (en) 1998-12-31 2005-02-22 Ingeneus Corporation Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
MX2018005950A (es) * 2015-11-12 2018-11-09 Baylor College Medicine Control exogeno de expresion genica en mamiferos a traves de modulacion mediada por aptameros de poliadenilacion.
AU2019381698A1 (en) * 2018-11-13 2021-05-27 Elevatebio Technologies, Inc. Encapsulated polynucleotides and methods of use
CN116555253A (zh) * 2022-01-30 2023-08-08 中国科学院分子细胞科学卓越创新中心 含高均一性poly(A)尾的mRNA及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08507203A (ja) * 1992-12-04 1996-08-06 イノーバー ラボラトリーズ，インコーポレイテッド 調節可能な核酸治療およびそれらの使用方法
US5663064A (en) * 1995-01-13 1997-09-02 University Of Vermont Ribozymes with RNA protein binding site
AU6591798A (en) * 1997-03-31 1998-10-22 Yale University Nucleic acid catalysts
EP1023312A4 (de) * 1997-10-07 2005-04-13 Smithkline Beecham Corp Methode zur beeinflussung der genexpression
WO2000024912A1 (en) * 1998-10-23 2000-05-04 The Children's Medical Center Corporation Use of a self-cleaving rna motif to modulate gene expression

Also Published As

Publication number Publication date
JP2003512059A (ja) 2003-04-02
WO2001029234A3 (en) 2001-11-29
CA2387185A1 (en) 2001-04-26
EP1092777A1 (de) 2001-04-18
NO20021713D0 (no) 2002-04-11
AU1514901A (en) 2001-04-30
WO2001029234A2 (en) 2001-04-26
PL355165A1 (en) 2004-04-05
HUP0203268A3 (en) 2005-08-29
MXPA02002864A (es) 2003-07-21
EP1224305A2 (de) 2002-07-24
HUP0203268A2 (hu) 2003-01-28
NO20021713L (no) 2002-06-12
CZ20021313A3 (cs) 2002-07-17
AU784832B2 (en) 2006-07-06
BR0014632A (pt) 2002-06-18
ZA200202823B (en) 2003-09-23
NZ518396A (en) 2004-01-30
KR20020037384A (ko) 2002-05-18
CN1377414A (zh) 2002-10-30

Similar Documents

Publication Publication Date Title
AU7680300A (en) Human dna sequences
ZA200110161B (en) Anti-avB3 recombinant human antibodies, nucleic acids encoding same and methods of use.
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
IL147541A0 (en) Oligonucleotides for inhibiting the expression of human eg5
EP1077996A4 (de) Menschliches edg3sb-gen
AU1608201A (en) Human zven proteins
HUP0104825A3 (en) Genes and proteins, and their use
AU2001286721A1 (en) Human interleukin-four induced protein
AU2002365202A8 (en) Synthetic genes for malarial proteins and methods of use
EP1186615A4 (de) PROTEIN UND DAFüR KODIERENDE DNS
IL143784A (en) Intermediates for the preparation of eprosartan
IL148572A0 (en) Self-cleaving rna sequences and their use for the control of protein synthesis
EP1194548A4 (de) Von pyrrhocoricin abstammende peptide und verfahren zu deren anwendung
AU7089800A (en) 29 human cancer associated proteins
GB9907553D0 (en) Purification of biological preparations
AU4483500A (en) Human membrane-associated proteins
AU2001295841A1 (en) Human dna sequences
EP1140121A4 (de) Kryogranulation von aktiviertem protein c
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9719359D0 (en) The Use of DNA Sequences
GB0112374D0 (en) Novel protein
EP1230928A4 (de) Verwendung von peptid
GB9908798D0 (en) Human homologues of fused gene
HUP0101911A3 (en) Novel sequence class of genes, corresponding proteins and the use of the same
AU2001241789A1 (en) Novel human gtpase activator proteins